Table 2.
Expression of afadin and clinicopathological characteristics in OS patients
| Item | N | Afadin (high) | Afadin (low) | P |
|---|---|---|---|---|
| Tumor tissue | 27 | 11 | 16 | < 0.001* |
| Normal | 10 | 8 | 2 | |
| Age (years) | ||||
| ≤ 19 | 15 | 6 | 9 | 0.341 |
| > 19 | 12 | 5 | 7 | |
| Gender | ||||
| Male | 16 | 6 | 10 | 1.000 |
| Female | 11 | 5 | 6 | |
| Stage | ||||
| IA–IIA | 10 | 4 | 6 | 0.584 |
| IIB–III | 17 | 7 | 10 | |
| Response to chemotherapy | ||||
| Poor | 9 | 3 | 6 | 0.127 |
| Good | 7 | 1 | 6 | |
| NA (n = 8) | 11 | |||
| Pulmonary metastasis | ||||
| + | 21 | 7 | 14 | < 0.001* |
| − | 6 | 4 | 2 | |
NA not available
* Statistical significance was found with the Chi-square test/Chi-square goodness-of-fit test